|Articles|February 1, 2012
- BioPharm International-02-01-2012
- Volume 25
- Issue 2
BioPharm International, February 2012 Issue (PDF)
Investing in BioPharma Outsourcing
Advertisement
Articles in this issue
over 13 years ago
Biomanufacturing Outsourcing Outlookover 13 years ago
Preparing For the New Chinaover 13 years ago
What the 2011 Census of India Reveals for Pharmaover 13 years ago
Saving the Next Generation of Regulatory Scientistsover 13 years ago
PQRI Case Study: Facility Biocontainment and Inactivationover 13 years ago
Assessing the Risk of Leachables from Single-Use Systemsover 13 years ago
Sustainable Investmentover 13 years ago
Understanding Gamma SterilizationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
Everything to Know About Cell and Gene Therapy in 2025
4
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
5
